Reshaping of the Biotech M&A Landscape The biotechnology industry has always been marked by innovation, rapid technological advancements and a drive to prevent, treat and cure disease. The prospect of mergers, acquisitions and joint collaboration deals with larger pharmaceutical giants has always served as fuel for the aspirations of small and mid-sized biotechnology companies. …
MedTech Marketing Pearls for FDA Clearance and Beyond Product marketing touches every function of a MedTech organization. I often describe it as the central spoke of the wheel, or the business lead that directs and guides each function in critical ways. Marketing know-how keeps a company ahead of market trends and perceptions. These insights …
MedTech Marketing Pearls for FDA Clearance and Beyond Read More »
It’s Time for MedTech to Recognize PFAS Urgency Over the past 85 years, perfluoroalkyl and polyfluoroalkyl substances (PFAS) have worked their way into numerous applications across countless industries. The MedTech industry is no exception. From dental floss to inhalers, ventilators, artificial heart pumps, pacemakers, contact lenses, surgical drapes and gowns, and countless other items, …
It’s Time for MedTech to Recognize PFAS Urgency Over the past 85 years, perfluoroalkyl and polyfluoroalkyl substances (PFAS) have worked their way into numerous applications across countless industries. The MedTech industry is no exception. From dental floss to inhalers, ventilators, artificial heart pumps, pacemakers, contact lenses, surgical drapes and gowns, and countless other items, …
The (Re-) Emergence of the Age of Enablement: Amgen v. Sanofi On May 18, 2023, biotech innovation suffered at least a temporary setback in Amgen v Sanofi in which a unanimous Supreme Court affirmed the rulings of the district court and the Court of Appeals for the Federal Circuit holding that Amgen’s challenged patent …
The (Re-) Emergence of the Age of Enablement: Amgen v. Sanofi Read More »
The (Re-) Emergence of the Age of Enablement: Amgen v. Sanofi On May 18, 2023, biotech innovation suffered at least a temporary setback in Amgen v Sanofi in which a unanimous Supreme Court affirmed the rulings of the district court and the Court of Appeals for the Federal Circuit holding that Amgen’s challenged patent …
The (Re-) Emergence of the Age of Enablement: Amgen v. Sanofi Read More »
Leveraging RFID and IoT to Increase Supply Chain Efficiency Supply chain disruptions present significant challenges for MedTech manufacturers and healthcare facilities, and can turn into life-threatening catastrophes for patients that depend on medical devices for care. Fortunately, device manufacturers and hospitals can take advantage of well-established technologies to help improve visibility so they can …
Leveraging RFID and IoT to Increase Supply Chain Efficiency Read More »
Partnering to Support Sustainability in the OR A recent study from Ethicon and the Cleveland Clinic outlined opportunities and barriers to better sustainability practices in operating rooms. We spoke with Vishnu Kalra, President of U.S. Ethicon, to learn more about the study’s findings, Ethicon’s efforts to develop more sustainable products and practices, and how …
AdvaMed Warns EPA of Massive Interruption to Patient Care In comments filed with the Environment Protection Agency (EPA), industry association AdvaMed called for continued cooperation between the medical device industry and the EPA as the regulations covering medical device sterilization using ethylene oxide (EtO) move forward. AdvaMed said if the proposals are finalized as …
AdvaMed Warns EPA of Massive Interruption to Patient Care Read More »
Device Development: A Hybrid Implantable Kidney Shuvo Roy, Ph.D., Professor of Bioengineering at UCSF and Technical Director of The Kidney Project, and his research partners have developed an artificial kidney constructed of semiconductor silicon wafers that remove waste and toxins from the blood and a cell therapy unit that replicates other kidney functions. Their …
